Bis-PEG7-NHS ester provides a long-chain homobifunctional PEG linker for bioconjugation via NHS ester chemistry. Ideal for constructing highly soluble, flexible ADC linkers with improved drug delivery performance.
Structure of 1334170-02-3
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Bis-PEG7-NHS ester is a crosslinking reagent widely used in bioconjugation and chemical biology. Here are some key applications of Bis-PEG7-NHS ester:
Protein-Protein Conjugation: Bis-PEG7-NHS ester is commonly used to link two proteins together, forming stable protein-protein conjugates. This technique is essential for creating bifunctional proteins for research and therapeutic purposes. It allows for the study of protein interactions and the development of multi-functional biotherapeutics.
Antibody-Drug Conjugates (ADCs): In the development of targeted cancer therapies, Bis-PEG7-NHS ester is used to attach cytotoxic drugs to antibodies. By forming a stable linker between the drug and the antibody, it ensures targeted delivery of the drug to cancer cells, minimizing off-target effects. This technology is pivotal for enhancing the efficacy and specificity of cancer treatments.
Surface Modification: Bis-PEG7-NHS ester is utilized to modify surfaces of various materials, such as nanoparticles, glass, and polymers. By attaching functional groups to surfaces, it enhances biocompatibility, reduces non-specific binding, and improves the stability of biomedical devices. This application is critical for the development of biosensors, implants, and diagnostic tools.
Peptide Synthesis: In peptide synthesis, Bis-PEG7-NHS ester is employed to link peptides together or to attach peptides to other molecules. This crosslinking is crucial for creating peptide arrays, peptide-based drugs, and for studying peptide interactions. It enables the design of complex peptide structures with improved stability and functionality.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00379 | Bis-PEG4-NHS ester | 1314378-11-4 | |
BADC-00380 | Bis-PEG3-NHS Ester | 1314378-16-9 | |
BADC-00960 | Bis-PEG6-NHS ester | 1526718-98-8 | |
BADC-01080 | Bis-PEG17-NHS ester | 2221948-93-0 | |
BADC-01081 | Bis-PEG25-NHS ester | 2221948-96-3 | |
BADC-01082 | Bis-PEG21-NHS ester | 2221948-98-5 | |
BADC-01083 | Bis-PEG13-NHS ester | 2221949-00-2 | |
BADC-01084 | Bis-PEG10-NHS ester | 2221949-02-4 | |
BADC-00381 | Bis-PEG2-NHS Ester | 65869-63-8 | |
BADC-00382 | Bis-PEG1-NHS ester | 65869-64-9 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.